New meningitis vaccine shows promise in large chinese trial
NCT ID NCT07135986
First seen Oct 31, 2025 · Last updated May 14, 2026 · Updated 31 times
Summary
This study tests a new vaccine designed to protect against four types of meningococcal bacteria that can cause meningitis and bloodstream infections. About 1,600 healthy children and teens aged 2 to 17 in China will receive either the new vaccine or a currently approved one. Researchers will check how well the vaccine triggers the immune system and monitor for any side effects over 6 months.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Investigational Site Number : 1561000
Nanning, Guangxi, 530028, China
-
Investigational Site Number : 1561001
Jingxi, 533899, China
-
Investigational Site Number : 1561002
Tengzhou, 543399, China
-
Investigational Site Number : 1561003
Liuzhou, 545100, China
Conditions
Explore the condition pages connected to this study.